首頁 > 市場調查報告書 > 醫療設備

心血管設備

全球體外二氧化碳去除裝置市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

市場調查報告書

商品編碼

1421121

全球體外二氧化碳去除裝置市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Extracorporeal CO2 Removal Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年01月01日 | 出版商:

Value Market Research | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2032 年，全球體外二氧化碳去除設備市場的市場規模將從 2023 年的 85.73 萬美元達到近 174.41 萬美元，2024 年至 2032 年研究期間的CAGR為 8.21%。

體外二氧化碳移除裝置是專門設計用於消除體外血液中二氧化碳 (CO2) 的醫療器材。這些設備在體外生命支持（ECLS）或體外膜氧合（ECMO）領域中發揮著至關重要的作用，為面臨嚴重呼吸衰竭或急性呼吸窘迫症候群（ARDS）的患者提供臨時援助。此技術的主要目標是減輕肺部壓力，促進癒合，同時確保足夠的氧合和二氧化碳去除。

市場動態

在多種因素的推動下，體外二氧化碳去除裝置市場正在大幅成長。嚴重呼吸衰竭、急性呼吸窘迫症候群 (ARDS) 和呼吸系統疾病的盛行率不斷上升，增加了對這些設備的需求，為對常規通氣無反應的患者提供了重要的治療途徑。技術進步在市場擴張中發揮關鍵作用，設備設計和薄膜技術的不斷創新提高了效率和效果。這些進步有助於開發更複雜的設備，提高重症監護環境中的性能、安全性和適用性。隨著醫療保健專業人員認知到管理嚴重呼吸系統疾病在提供肺部休息和支持方面的作用，人們越來越意識到管理嚴重呼吸系統疾病的好處，這有助於市場成長。包括慢性阻塞性肺病（COPD）在內的呼吸系統疾病的發生率不斷上升，增加了對這些支持性干預措施的需求。 COVID-19 大流行進一步強調了先進呼吸支援系統（包括這些設備）在管理嚴重呼吸窘迫方面的重要性。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球體外二氧化碳去除設備市場的各個細分市場進行了包容性評估。體外二氧化碳去除裝置產業的成長和趨勢為本研究提供了整體方法。

市場區隔

體外二氧化碳去除裝置市場報告的這一部分提供了國家和區域層面的詳細資料，從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

體外二氧化碳機
免洗用品
其他

按應用

急性呼吸窘迫症候群（Ards）
慢性阻塞性肺病（COPD）
肺移植橋
其他

透過訪問

靜脈
動靜脈

按最終用途

醫院
門診手術中心
診所
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲體外二氧化碳去除設備市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。體外二氧化碳去除設備市場的主要參與者包括 Medtronic、Getinge AB、Xenios AG、ALung Technologies, Inc.、ESTOR SPA、Medica SPA、Aferetica srl。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按產品分類的市場吸引力分析
- 市場吸引力分析：依應用分類
- 按訪問進行的市場吸引力分析
- 按最終用途分類的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球體外二氧化碳移除裝置市場分析：依產品

按產品概述
歷史和預測數據
按產品分析
體外二氧化碳機
免洗用品
其他

第 6 章：全球體外二氧化碳移除裝置市場分析：依應用分類

概述：按應用
歷史和預測數據
分析：按應用
急性呼吸窘迫症候群（ARDS）
慢性阻塞性肺病（COPD）
肺移植橋
其他

第 7 章：全球體外二氧化碳移除裝置市場分析：按訪問方式

按訪問方式概述
歷史和預測數據
透過訪問進行分析
靜脈
動靜脈

第 8 章：全球體外二氧化碳移除裝置市場分析：依最終用途分類

按最終用途分類的概述
歷史和預測數據
按最終用途分析
醫院
門診手術中心
診所
其他

第 9 章：全球體外二氧化碳移除裝置市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：體外二氧化碳移除裝置公司的競爭格局

體外二氧化碳去除裝置市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

公司股份分析
市場集中度
Medtronic

公司簡介
公司收入
產品
最近的發展

Getinge AB

公司簡介
公司收入
產品
最近的發展

Xenios AG

公司簡介
公司收入
產品
最近的發展

ALung Technologies Inc.

公司簡介
公司收入
產品
最近的發展

ESTOR SPA

公司簡介
公司收入
產品
最近的發展

Medica SPA

公司簡介
公司收入
產品
最近的發展

Aferetica srl

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112113388

The global demand for Extracorporeal CO2 Removal Devices Market is presumed to reach the market size of nearly USD 174.41 MN by 2032 from USD 85.73 MN in 2023 with a CAGR of 8.21% under the study period 2024 - 2032.

Extracorporeal carbon dioxide removal devices are medical instruments specifically engineered to eliminate carbon dioxide (CO2) from the bloodstream external to the body. These devices play a crucial role in the realm of extracorporeal life support (ECLS) or extracorporeal membrane oxygenation (ECMO), providing temporary assistance to patients facing severe respiratory failure or acute respiratory distress syndrome (ARDS). The primary objective of this technology is to alleviate the strain on the lungs, allowing for healing while ensuring sufficient oxygenation and CO2 removal.

MARKET DYNAMICS

The market for extracorporeal carbon dioxide removal devices is witnessing substantial growth, driven by various factors. The escalating prevalence of severe respiratory failure, acute respiratory distress syndrome (ARDS), and respiratory conditions are amplifying the demand for these devices, offering a critical therapeutic avenue for patients unresponsive to conventional ventilation. Technological advancements play a pivotal role in market expansion, with continuous innovations in device design and membrane technology enhancing efficiency and effectiveness. These advancements contribute to the development of more sophisticated devices that improve performance, safety, and applicability in critical care settings. The increasing awareness of the benefits of managing severe respiratory conditions is contributing to market growth as healthcare professionals recognize its role in providing lung rest and support. The rising incidence of respiratory diseases, including chronic obstructive pulmonary disease (COPD), adds to the demand for these supportive interventions. The COVID-19 pandemic has further emphasized the importance of advanced respiratory support systems, including these devices, in managing severe respiratory distress.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of extracorporeal co2 removal devices. The growth and trends of extracorporeal co2 removal devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the extracorporeal co2 removal devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Extracorporeal CO2 Machines
Disposables
Others

By Application

Acute Respiratory Distress Syndrome (Ards)
Chronic Obstructive Pulmonary Disease (Copd)
Bridge To Lung Transplant
Others

By Access

Venovenous
Arteriovenous

By End-Use

Hospitals
Ambulatory Surgical Centers
Clinics
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Extracorporeal CO2 Removal Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Extracorporeal CO2 Removal Devices market include Medtronic, Getinge AB, Xenios AG, ALung Technologies, Inc., ESTOR S.P.A., Medica S.P.A., Aferetica srl. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . EXTRACORPOREAL CO2 REMOVAL DEVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Access
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Extracorporeal CO2 Machines Historic and Forecast Sales by Regions
5.5 Disposables Historic and Forecast Sales by Regions
5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Acute Respiratory Distress Syndrome (ARDS) Historic and Forecast Sales by Regions
6.5 Chronic Obstructive Pulmonary Disease (COPD) Historic and Forecast Sales by Regions
6.6 Bridge to Lung Transplant Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET ANALYSIS BY ACCESS

7.1 Overview by Access
7.2 Historical and Forecast Data
7.3 Analysis by Access
7.4 Venovenous Historic and Forecast Sales by Regions
7.5 Arteriovenous Historic and Forecast Sales by Regions

8 . GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET ANALYSIS BY END-USE

8.1 Overview by End-use
8.2 Historical and Forecast Data
8.3 Analysis by End-use
8.4 Hospitals Historic and Forecast Sales by Regions
8.5 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
8.6 Clinics Historic and Forecast Sales by Regions
8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. South East Asia Sales Analysis
- 9.5.10. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE EXTRACORPOREAL CO2 REMOVAL DEVICES COMPANIES

10.1. Extracorporeal Co2 Removal Devices Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF EXTRACORPOREAL CO2 REMOVAL DEVICES INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Medtronic
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Getinge AB
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Xenios AG
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. ALung Technologies Inc.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. ESTOR S.P.A.
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Medica S.P.A.
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Aferetica srl
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments